BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miyachi K, Sasaki K, Onodera S, Taguchi T, Nagamachi M, Kaneko H, Sunagawa M. Correlation between survivin mRNA expression and lymph node metastasis in gastric cancer. Gastric Cancer. 2003;6:217-224. [PMID: 14716515 DOI: 10.1007/s10120-003-0255-2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Aubets E, Griera R, Felix AJ, Rigol G, Sikorski C, Limón D, Mastrorosa C, Busquets MA, Pérez-García L, Noé V, Ciudad CJ. Synthesis and validation of DOPY: A new gemini dioleylbispyridinium based amphiphile for nucleic acid transfection. Eur J Pharm Biopharm 2021;165:279-92. [PMID: 34033881 DOI: 10.1016/j.ejpb.2021.05.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Rafatmanesh A, Behjati M, Mobasseri N, Sarvizadeh M, Mazoochi T, Karimian M. The survivin molecule as a double-edged sword in cellular physiologic and pathologic conditions and its role as a potential biomarker and therapeutic target in cancer. J Cell Physiol 2020;235:725-44. [PMID: 31250439 DOI: 10.1002/jcp.29027] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
3 Kamra M, Maiti B, Dixit A, Karande AA, Bhattacharya S. Tumor Chemosensitization through Oncogene Knockdown Mediated by Unique α-Tocopherylated Cationic Geminis. Biomacromolecules 2019;20:1555-66. [DOI: 10.1021/acs.biomac.8b01751] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
4 Galliera E, Luzzati A, Perrucchini G, Gagliano F, Mels LC, Banfi G, Romanelli MMC, Drago L. Bone formation and resorption markers as diagnostic tools for bone metastases evaluation. Int J Biol Markers 2012;27:395-9. [DOI: 10.5301/jbm.2012.9579] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
5 Li CR, Li HL. Relationship between Survivin and gastric cancer. Shijie Huaren Xiaohua Zazhi 2014; 22(33): 5079-5085 [DOI: 10.11569/wcjd.v22.i33.5079] [Reference Citation Analysis]
6 Zhang L, Liang H, Cao W, Xu R, Ju XL. Downregulation of survivin by siRNA inhibits invasion and promotes apoptosis in neuroblastoma SH-SY5Y cells. Braz J Med Biol Res 2014;47:548-53. [PMID: 24863648 DOI: 10.1590/1414-431x20143459] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
7 Tyagi A, Raina K, Shrestha SP, Miller B, Thompson JA, Wempe MF, Agarwal R, Agarwal C. Procyanidin B2 3,3(″)-di-O-gallate, a biologically active constituent of grape seed extract, induces apoptosis in human prostate cancer cells via targeting NF-κB, Stat3, and AP1 transcription factors. Nutr Cancer 2014;66:736-46. [PMID: 24191894 DOI: 10.1080/01635581.2013.783602] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
8 Krieg A, Baseras B, Tomczak M, Verde PE, Stoecklein NH, Knoefel WT. Role of survivin as prognostic and clinicopathological marker in gastric cancer: a meta-analysis. Mol Biol Rep. 2013;40:5501-5511. [PMID: 23948878 DOI: 10.1007/s11033-013-2650-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
9 Ichikawa H, Kanda T, Kosugi S, Kawachi Y, Sasaki H, Wakai T, Kondo T. Laser microdissection and two-dimensional difference gel electrophoresis reveal the role of a novel macrophage-capping protein in lymph node metastasis in gastric cancer. J Proteome Res 2013;12:3780-91. [PMID: 23782053 DOI: 10.1021/pr400439m] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
10 Li R, Chen W, Pang X, Tian W, Wang W, Zhang X. Combined effect of sCD40L and PI3K siRNA on transplanted tumours growth and microenvironment in nude mice with gastric cancer. Mol Biol Rep 2012;39:8755-61. [DOI: 10.1007/s11033-012-1736-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
11 Lee KH, Choi EY, Koh SA, Kim MK, Kim KO, Lee SH, Jang BI, Kim SW, Kim SW, Song SK, Choi JH, Kim JR. Down-regulation of survivin suppresses uro-plasminogen activator through transcription factor JunB. Exp Mol Med 2011;43:501-9. [PMID: 21734448 DOI: 10.3858/emm.2011.43.9.057] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
12 Wang XR, Li XN, Bai GH, Guo YD. Significance of expression of nuclear PTEN and survivin in gastric cancer. Shijie Huaren Xiaohua Zazhi 2011; 19(28): 2974-2978 [DOI: 10.11569/wcjd.v19.i28.2974] [Reference Citation Analysis]
13 Cao W, Yang W, Li H, Lou G, Jiang J, Geng M, Xi W, Ren R, Qu Q, Jin X. Using detection of survivin-expressing circulating tumor cells in peripheral blood to predict tumor recurrence following curative resection of gastric cancer. J Surg Oncol. 2011;103:110-115. [PMID: 21259243 DOI: 10.1002/jso.21777] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
14 Zhang W, Jiang B, Guo Z, Sardet C, Zou B, Lam CSC, Li J, He M, Lan H, Pang R, Hung IFN, Tan VPY, Wang J, Wong BCY. Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancer. Carcinogenesis 2010;31:1220-9. [DOI: 10.1093/carcin/bgq094] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 3.9] [Reference Citation Analysis]
15 Li F, Cheng Q, Ling X, Stablewski A, Tang L, Foster BA, Johnson CS, Rustum YM, Porter CW. Generation of a novel transgenic mouse model for bioluminescent monitoring of survivin gene activity in vivo at various pathophysiological processes: survivin expression overlaps with stem cell markers. Am J Pathol 2010;176:1629-38. [PMID: 20133811 DOI: 10.2353/ajpath.2010.090414] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
16 Wang T, Qian X, Wang Z, Wang L, Yu L, Ding Y, Liu B. Detection of cell-free BIRC5 mRNA in effusions and its potential diagnostic value for differentiating malignant and benign effusions. Int J Cancer 2009;125:1921-5. [DOI: 10.1002/ijc.24516] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
17 Yang L, Zhu H, Zhou B, Gu H, Yan H, Tang N, Dong H, Sun Q, Cong R, Chen G, Wang B. The association between the survivin C-31G polymorphism and gastric cancer risk in a Chinese population. Dig Dis Sci 2009;54:1021-8. [PMID: 18716870 DOI: 10.1007/s10620-008-0441-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
18 Shen J, Liu J, Long Y, Miao Y, Su M, Zhang Q, Han H, Hao X. Knockdown of survivin expression by siRNAs enhances chemosensitivity of prostate cancer cells and attenuates its tumorigenicity. Acta Biochim Biophys Sin (Shanghai) 2009;41:223-30. [PMID: 19280061 DOI: 10.1093/abbs/gmp005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
19 Ding YP, Zou SY, Zhao HH. Survivin expression in gastric carcinoma and its targeted therapy. Shijie Huaren Xiaohua Zazhi 2008; 16(31): 3528-3532 [DOI: 10.11569/wcjd.v16.i31.3528] [Reference Citation Analysis]
20 Briggs CD, Neal CP, Mann CD, Steward WP, Manson MM, Berry DP. Prognostic molecular markers in cholangiocarcinoma: a systematic review. Eur J Cancer. 2009;45:33-47. [PMID: 18938071 DOI: 10.1016/j.ejca.2008.08.024] [Cited by in Crossref: 67] [Cited by in F6Publishing: 59] [Article Influence: 4.5] [Reference Citation Analysis]
21 Chen T, Deng C. Inhibitory effect of siRNA targeting survivin in gastric cancer MGC-803 cells. International Immunopharmacology 2008;8:1006-11. [DOI: 10.1016/j.intimp.2008.03.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
22 Bury JM, Skrzypek A, Mach-lichota E, Dąbrowski A. Survivin in cancer diagnosis and therapy - a review. Annales UMCS, Medicina 2008;63:78-84. [DOI: 10.2478/v10079-008-0012-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
23 Ye CP, Qiu CZ, Huang ZX, Su QC, Zhuang W, Wu RL, Li XF. Relationship between survivin expression and recurrence, and prognosis in hepatocellular carcinoma. World J Gastroenterol 2007; 13(46): 6264-6268 [PMID: 18069771 DOI: 10.3748/wjg.v13.i46.6264] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
24 Ribeiro DA, Kitakawa D, Domingues MAC, Cabral LAG, Marques MEA, Salvadori DMF. Survivin and inducible nitric oxide synthase production during 4NQO-induced rat tongue carcinogenesis: A possible relationship. Experimental and Molecular Pathology 2007;83:131-7. [DOI: 10.1016/j.yexmp.2007.02.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
25 Wang TT, Qian XP, Liu BR. Survivin: Potential role in diagnosis, prognosis and targeted therapy of gastric cancer. World J Gastroenterol 2007; 13(20): 2784-2790 [PMID: 17569112 DOI: 10.3748/wjg.v13.i20.2784] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 39] [Article Influence: 2.2] [Reference Citation Analysis]
26 Yang D, Schneider S, Azuma M, Iqbal S, El-Khoueiry A, Groshen S, Agafitei D, Danenberg KD, Danenberg PV, Ladner RD. Gene expression levels of epidermal growth factor receptor, survivin, and vascular endothelial growth factor as molecular markers of lymph node involvement in patients with locally advanced rectal cancer. Clin Colorectal Cancer. 2006;6:305-311. [PMID: 17241515 DOI: 10.3816/CCC.2006.n.049] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
27 Osaka E, Suzuki T, Osaka S, Yoshida Y, Sugita H, Asami S, Tabata K, Sugitani M, Nemoto N, Ryu J. Survivin expression levels as independent predictors of survival for osteosarcoma patients. J Orthop Res 2007;25:116-21. [PMID: 17034065 DOI: 10.1002/jor.20291] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
28 Rosato A, Pivetta M, Parenti A, Iaderosa GA, Zoso A, Milan G, Mandruzzato S, Del Bianco P, Ruol A, Zaninotto G. Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma. Int J Cancer. 2006;119:1717-1722. [PMID: 16671090 DOI: 10.1002/ijc.21923] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 2.6] [Reference Citation Analysis]
29 Lee GH, Joo YE, Koh YS, Chung IJ, Park YK, Lee JH, Kim HS, Choi SK, Rew JS, Park CS, Kim SJ. Expression of survivin in gastric cancer and its relationship with tumor angiogenesis. Eur J Gastroenterol Hepatol 2006;18:957-63. [PMID: 16894308 DOI: 10.1097/01.meg.0000230086.83792.56] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
30 Deng H, Wu R, Chen Y, Liu L. STAT1 and survivin expression in full lymph node examined gastric cancer by using tissue microarray technique. Chinese German J Clin Oncol 2006;5:249-52. [DOI: 10.1007/s10330-006-0468-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
31 Osaka E, Suzuki T, Osaka S, Yoshida Y, Sugita H, Asami S, Tabata K, Hemmi A, Sugitani M, Nemoto N, Ryu J. Survivin as a prognostic factor for osteosarcoma patients. Acta Histochem Cytochem 2006;39:95-100. [PMID: 17327929 DOI: 10.1267/ahc.06005] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 2.9] [Reference Citation Analysis]
32 Lv XJ, Wu DY, Yang L, Zhang SM, Xin Y. Significance of survivin and caspase-3 protein expression in gastric precancerous lesions and gastric cancer tissue. Shijie Huaren Xiaohua Zazhi 2005; 13(16): 1951-1955 [DOI: 10.11569/wcjd.v13.i16.1951] [Reference Citation Analysis]
33 Kawakami H, Tomita M, Matsuda T, Ohta T, Tanaka Y, Fujii M, Hatano M, Tokuhisa T, Mori N. Transcriptional activation of survivin through the NF-kappaB pathway by human T-cell leukemia virus type I tax. Int J Cancer 2005;115:967-74. [PMID: 15729715 DOI: 10.1002/ijc.20954] [Cited by in Crossref: 113] [Cited by in F6Publishing: 119] [Article Influence: 6.3] [Reference Citation Analysis]
34 Zhao XH, Gu SZ, Tian HG, Quan P, Pan BR. Clinical significance of expression of apoptotic signal proteins in gastric carcinoma tissue. World J Gastroenterol 2005; 11(25): 3846-3849 [PMID: 15991280 DOI: 10.3748/wjg.v11.i25.3846] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
35 Kim M, Lim K, Kim J, Nam I, Lee J, Myoung H. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma. Cancer Letters 2005;224:253-61. [DOI: 10.1016/j.canlet.2005.01.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
36 Zhang J, Zhu ZG, Ji J, Yuan F, Yu YY, Liu BY, Lin YZ. Transcription factor Sp1 expression in gastric cancer and its relationship to long-term prognosis. World J Gastroenterol 2005; 11(15): 2213-2217 [PMID: 15818728 DOI: 10.3748/wjg.v11.i15.2213] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 37] [Article Influence: 1.8] [Reference Citation Analysis]
37 Tong QS, Zheng LD, Chen FM, Zeng FQ, Wang L, Dong JH, Lu GC. Selection of optimal antisense accessible sites of survivin and its application in treatment of gastric cancer. World J Gastroenterol 2005; 11(5): 634-640 [PMID: 15655812 DOI: 10.3748/wjg.v11.i5.634] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
38 Murakawa K, Tada M, Takada M, Tamoto E, Shindoh G, Teramoto K, Matsunaga A, Komuro K, Kanai M, Kawakami A, Fujiwara Y, Kobayashi N, Shirata K, Nishimura N, Okushiba S, Kondo S, Hamada J, Katoh H, Yoshiki T, Moriuchi T. Prediction of lymph node metastasis and perineural invasion of biliary tract cancer by selected features from cDNA array data. J Surg Res. 2004;122:184-194. [PMID: 15555617 DOI: 10.1016/j.jss.2004.06.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
39 Sugahara K, Uemura A, Harasawa H, Nagai H, Hirakata Y, Tomonaga M, Murata K, Sohda H, Nakagoe T, Shibasaki S, Yamada Y, Kamihira S. Clinical relevance of survivin as a biomarker in neoplasms, especially in adult T-cell leukemias and acute leukemias. Int J Hematol 2004;80:52-8. [PMID: 15293568 DOI: 10.1532/ijh97.04031] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.2] [Reference Citation Analysis]